21 C.F.R. § 520.540c

Dexamethasone chewable tablets.

Last amended: 2017Year: 2026Length: 140 wordsSubsections: 3Official source

Cite as 21 C.F.R. § 520.540c (2026)

(a) Specifications. Each half-scored tablet contains 0.25 milligram of dexamethasone. (b) Sponsor. See No. 051031 in § 510.600(c) of this chapter. (c) Conditions of use in dogs —(1) Amount. Administer by free-choice feeding or crumbled over food 0.25 to 1.25 milligrams daily in single or two divided doses until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced by 0.125 milligram per day until maintenance level is achieved. (2) Indications for use. As supportive therapy in nonspecific dermatosis and inflammatory conditions. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [44 FR 7130, Feb. 6, 1979, as amended at 56 FR 50653, Oct. 8, 1991; 60 FR 55659, Nov. 2, 1995; 79 FR 28820, May 20, 2014; 82 FR 11508, Feb. 24, 2017]
Cross-references to the CFR
510.600
21 C.F.R. § 520.540c: Dexamethasone chewable tablets. | Justis AI